Ganaxalone ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
158結節性硬化症1

158. 結節性硬化症


臨床試験数 : 112 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05323734
(ClinicalTrials.gov)
April 1, 202221/3/2022Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related EpilepsyA Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC)Tuberous Sclerosis ComplexDrug: Ganaxalone;Drug: PlaceboMarinus PharmaceuticalsNULLRecruiting1 Year65 YearsAll162Phase 3United States;Canada;France;Germany;Israel;Italy;Spain;United Kingdom